Artículos de revistas
RETRACTED ARTICLE: Fatal factitious Cushing syndrome (Münchhausen’s syndrome) in a patient with macroprolactinoma and silent corticotrophinoma: case report and literature review
Fecha
2015Registro en:
Clinical Diabetes and Endocrinology. 2015 Jun 04;1(1):3
10.1186/s40842-015-0002-8
Autor
Minanni, Carlos André
Cardoso, Ana Luiza De Almeida
Albuquerque, Edoarda Vasco de Albuquerque
Brito, Luciana Pinto
Lopes, Ludmilla Malveira Lima
Glezer, Andrea
Verduguez, Elisa Del Rosario Ugarte
Mendonça, Berenice Bilharinho de
Bronstein, Marcello Delano
Machado, Marcio Carlos
Fragoso, Maria Candida Barisson Villares
Institución
Resumen
Abstract
Münchhausen’s syndrome (MS) is a chronic factitious disorder
characterized by the intentional production of clinical symptoms without external
incentive. One type of MS is factitious Cushing syndrome, an extremely rare clinical
situation in which the diagnosis is challenging mainly due to interference of the
exogenous medication in cortisol immunoassays. We described a 26-year-old woman who
was originally diagnosed with a macroprolactinoma and during follow-up developed
clinical and laboratorial hypercortisolism. A transsphenoidal surgery was performed
and immunohistochemistry revealed positive and diffuse staining for both hormones.
Four years later, her hypercortisolism recurred and the confirmation of factitious
Cushing syndrome was delayed due to conflicting laboratorial results.
There are few cases in the literature of factitious Cushing syndrome,
and only one had a fatal outcome. The diagnosis of this condition is complex and
includes cyclic Cushing syndrome in the differential diagnosis. These patients have
high morbidity and increased mortality risk and are likely to have other psychiatric
disorders. Prednisone was identified as the culprit in the majority of the
cases.